GSK to pay $1 billion for exclusive license to J&J’s hepatitis B therapy
(Reuters) -GSK will pay about $1 billion for exclusive rights to further develop and commercialize Johnson & Johnson’s hepatitis B…
October 31, 2023
Nvidia shares drop after report of canceled China orders
By Chibuike Oguh NEW YORK (Reuters) -Shares of Nvidia Corp dropped by about 5% to a near five-month low on…
BP shares slump as Q3 profit misses forecast on weak gas
By Ron Bousso and Shadia Nasralla LONDON (Reuters) – BP on Tuesday reported third-quarter earnings of $3.3 billion, missing analysts’…
Amgen sales rise, but shares off as investors await obesity data
By Deena Beasley (Reuters) -Amgen on Tuesday said third-quarter sales rose 5%, but a full-year sales forecast raise only reflected…
Apple revamps Mac lineup and pricing with new family of chips
By Stephen Nellis SAN FRANCISCO (Reuters) -Apple on Monday introduced new MacBook Pro and iMac computers and three new chips…